a Faculty of Medicine & Health University of Newcastle , School of Medicine & Public Health , Callaghan , NSW , Australia.
b School of Biomedical Sciences & Pharmacy, Faculty of Health & Medicine , University of Newcastle , Newcastle , NSW , Australia.
Expert Rev Gastroenterol Hepatol. 2019 May;13(5):437-445. doi: 10.1080/17474124.2019.1596025. Epub 2019 Mar 27.
Primary atopic disorders can be classified as heritable genetic disorders presenting with deregulated pathogenic allergic effector responses irrespective of sensitization. In the last decade, there are parallel rises in the burden of atopic and gastrointestinal (GI) diseases. Areas covered: There is increasing recognition of an association between atopy and GI disease through immune dysregulation, the microbiome and shared genetic pathways. Since the first article on atopy and the GI tract in 2014 in this journal, many more studies have shed light on the shared pathways in these diseases, particularly in the field of eosinophilic GI disease, functional GI disorders, and inflammatory bowel disease. Expert opinion: Understanding the links with common mechanisms in atopy and GI diseases that may lead to better targeting of treatment through manipulation of immune mechanisms, the microbiome, genetics, food allergens and specific GI diseases such as inflammatory bowel disease, functional GI disorders.
特应性主要障碍可归类为遗传性疾病,表现为过敏效应反应失调,而与致敏无关。在过去十年中,特应性和胃肠道(GI)疾病的负担都在增加。
涵盖领域:通过免疫失调、微生物组和共同遗传途径,人们越来越认识到特应性和 GI 疾病之间的关联。自 2014 年本期刊登第一篇关于特应性和胃肠道的文章以来,更多的研究揭示了这些疾病的共同途径,特别是在嗜酸性粒细胞性胃肠道疾病、功能性胃肠道疾病和炎症性肠病领域。
专家意见:了解特应性和胃肠道疾病之间的共同机制联系,可能通过免疫机制、微生物组、遗传学、食物过敏原和特定胃肠道疾病(如炎症性肠病、功能性胃肠道疾病)的靶向治疗来改善治疗效果。
Expert Rev Gastroenterol Hepatol. 2019-3-27
Expert Rev Gastroenterol Hepatol. 2014-3
Allergy. 2016-9
Int Arch Allergy Immunol. 2020
Gastroenterology. 2016-5
J Clin Invest. 2019-3-11
Ann Am Thorac Soc. 2016-3
Autoimmun Rev. 2022-1